McKinsey is close to paying more than $600mn to settle a criminal investigation into its work advising US opioid manufacturers on how to boost sales, following claims it fuelled the country’s ...

McKinsey & Co is in the final stages of negotiating a deferred prosecution agreement to resolve a U.S. criminal investigation ...

Global consulting giant McKinsey & Company is close to finalizing a $600 million settlement with the United States government ...

At the time of the settlement with the US states, Sneader apologised for McKinsey’s opioid work, saying it “did not adequately acknowledge the tragic consequences of the epidemic unfolding in ...

Exclusive-McKinsey Nears Deferred Prosecution Pact in US Opioid Probe ... the people said. The settlement, expected to be unveiled before the end of the year, would result in prosecutors seeking ...

McKinsey & Co is negotiating a deferred prosecution agreement with U.S. authorities to resolve a criminal investigation tied to its role in boosting opioid sales, allegedly contributing to the crisis.

In 2019, McKinsey announced it would no longer advise clients on opioid-related businesses. The company has maintained that none of its settlements contain admissions of liability or wrongdoing.

BOSTON (Reuters) - McKinsey & Co is in the final stages of negotiating a deferred prosecution agreement to resolve a U.S. criminal investigation into the consulting firm's work helping opioid ...